These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 455871)

  • 21. Serum LDL cholesterol, the LDL/HDL cholesterol ratio and liver microsomal enzyme induction evaluated by antipyrine kinetics.
    Luoma PV; Sotaniemi EA; Arranto AJ
    Scand J Clin Lab Invest; 1983 Dec; 43(8):671-5. PubMed ID: 6665516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Saliva and plasma clearance of antipyrine as reflectors of liver function.
    Luoma PV; Sotaniemi EA
    Eur J Drug Metab Pharmacokinet; 1981; 6(4):261-4. PubMed ID: 7333326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Research on the eventual enzymatic induction activity of cetiedil in rat and man.
    Larousse C; Kergueris MF; Le Normand Y; Visset J
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):195-9. PubMed ID: 7390670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative enzyme-inducing effects of chlorpromazine and fluphenazine therapies in psychotic patients.
    Harman AW; Frewin DB; Priestly BG
    Psychopharmacology (Berl); 1980; 69(1):35-7. PubMed ID: 6771823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants.
    Pirttiaho HI; Sotaniemi EA; Pelkonen RO; Pitkänen U
    Eur J Clin Pharmacol; 1982; 22(5):441-5. PubMed ID: 7117357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further observations on relationships between antipyrine half-life, clearance and volume of distribution: an appraisal of alternative kinetic parameters used to assess the elimination of antipyrine.
    Sultatos LG; Dvorchik BH; Vesell ES; Shand DG; Branch RA
    Clin Pharmacokinet; 1980; 5(3):263-73. PubMed ID: 7389235
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of enzyme induction on diazepam metabolism in man.
    Ohnhaus EE; Park BK; Colombo JP; Heizmann P
    Br J Clin Pharmacol; 1979 Dec; 8(6):557-63. PubMed ID: 42427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzyme induction in sheep: effects of phenobarbital on in vivo and in vitro drug metabolism.
    Shetty SN; Himes JA; Edds GT
    Am J Vet Res; 1972 May; 33(5):935-42. PubMed ID: 4112405
    [No Abstract]   [Full Text] [Related]  

  • 29. Changes in D-glucaric acid excretion in relationship to alterations in the rate of antipyrine metabolism in man.
    Hunter J; Burnham WR; Chasseaud LF; Down W
    Biochem Pharmacol; 1974 Sep; 23(17):2480-3. PubMed ID: 4429583
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
    Szakács T; Veres Z; Vereczkey L
    Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impairment of hepatic drug metabolism in patients with acute viral hepatitis.
    Narang AP; Datta DV; Nath N; Mathur VS
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):255-8. PubMed ID: 7166177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug metabolism in hepatosplenic schistosomiasis in the Sudan: a study with antipyrine.
    Homeida M; Salih SY; Branch RA
    Gut; 1978 Sep; 19(9):808-11. PubMed ID: 710970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of fenfluramine on disposition and rate of antipyrine elimination.
    O'Malley K; Stevenson IH; West M
    Pharmacology; 1975; 13(1):12-9. PubMed ID: 1153500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of rifampicin, phenobarbital and cimetidine on mixed function monooxygenase in extensive and poor metabolizers of debrisoquine.
    Leclercq V; Desager JP; Horsmans Y; Van Nieuwenhuyze Y; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1989 Dec; 27(12):593-8. PubMed ID: 2613393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the half-life of antipyrine in plasma, whole blood and saliva of man.
    van Boxtel CJ; Wilson JT; Lindgren S; Sjöqvist F
    Eur J Clin Pharmacol; 1976 Feb; 9(4):327-32. PubMed ID: 971716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spironolactone--a weak enzyme inducer in man.
    Taylor SA; Rawlins MD; Smith SE
    J Pharm Pharmacol; 1972 Jul; 24(7):578-9. PubMed ID: 4403853
    [No Abstract]   [Full Text] [Related]  

  • 37. Antipyrine metabolite kinetics in phenobarbital and beta-naphthoflavone-induced rats.
    Rhodes JC; Houston JB
    Drug Metab Dispos; 1983; 11(2):131-6. PubMed ID: 6133717
    [No Abstract]   [Full Text] [Related]  

  • 38. Dose-dependent enzyme induction.
    Breckenridge A; Davies DS; Davies L; Orme M
    Br J Pharmacol; 1973 Mar; 47(3):616P-617P. PubMed ID: 4730838
    [No Abstract]   [Full Text] [Related]  

  • 39. Impaired enzyme induction by rifampicin in the elderly.
    Twum-Barima Y; Finnigan T; Habash AI; Cape RD; Carruthers SG
    Br J Clin Pharmacol; 1984 May; 17(5):595-7. PubMed ID: 6733008
    [No Abstract]   [Full Text] [Related]  

  • 40. Liver blood flow and enzyme induction in man.
    Ohnhaus EE; Noelpp UB; Ramos MR
    Hepatogastroenterology; 1985 Apr; 32(2):61-4. PubMed ID: 4007764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.